The collaboration with UBC is focused on developing machine-learning based technology to improve the quality of our 3D printing.
Aspect is hosting a hands-on bioprinting session at the TERMIS-EU Workshop in Nantes, France, August 26-27.
The presentation will highlight milestone achievements to develop human liver tissue using Aspect’s microfluidic 3D bioprinting platform.
McMaster University will use the RX1 3D Bioprinter to investigate novel disease mechanisms for chronic lung diseases.
This $2.2M project is made possible by contributions from CQDM, CCS, Merck, GSK, Aspect Biosystems, and McGill University.
Aspect collaborates with the Center for Minimally Invasive Therapies (C-MIT) at the University of California, Los Angeles (UCLA).
Aspect will join 15 ventures from around the world in a multi-year collaboration to help align the future of work with social equity.
Aspect Biosystems Named 2019 Growth Stage Company of the Year by LifeSciences BC.
The National Research Council of Canada and Aspect Biosystems are collaborating to develop a 3D model of the blood-brain barrier.
Aspect is presenting preclinical data from recent studies focused on developing a bioprinted meniscus tissue for surgical implantation.
The Maastricht Institute for Technology-Inspired Regenerative Medicine will develop kidney tissue using an RX1™ Bioprinting Platform.
Government of Canada invests nearly $20M in top British Columbia companies in 2018.
BIOTECanada Gold Leaf Award Winner for Emerging Company of the Year 2018: Aspect Biosystems.
Spiro joins Aspect following his role as Biology Director at GlaxoSmithKline and as a Faculty Member at Northwestern University.
"Aspect Biosystems: Building a Global Discovery Ecosystem from Right Here in Canada" - BIOTECanada insights Magazine, Fall 2018
Aspect Biosystems announces collaboration with multinational JSR Corporation to develop human liver tissue.
UBC Applied Science profiles our CEO to learn how his focus shifted from academic to industry.
The Stem Cell Networks appoints Tamer Mohamed, CEO of Aspect Biosystems, to its Board of Directors
Our collaborators from the Frampton Lab at Dalhousie University are presenting research they performed in collaboration with Aspect.
Genome BC Invests $1 million in Funding to Top Canadian 3D Bioprinting Company Aspect Biosystems.
Aspect Biosystems is co-hosting this International Research Roundtable with the University of British Columbia, June 10-12, 2018. Join us!
Aspect featured by BBC, highlighting how synthetics are beginning to have a profound effect on medicine.
Highlighting the key events we attended in 2018.
BCBusiness includes Aspect CEO among the top young business leaders in BC
This Ready to Rocket list profiles the highest growth tech companies in BC's life science sector.
Highlighting the key events we attended in 2017.
Aspect has announced the completion of its first institutionally led round of financing.
CEO Tamer Mohamed has been selected by Business in Vancouver for their annual Forty Under 40 Awards.
Aspect enters international research collaboration with InSCREENeX and Fraunhofer ITEM to develop bioprinted models of tissue contraction.
We're proud to be named one of the CIX (Canadian Innovation Exchange) Top 20 Most Innovative Canadian Technology Companies...
The Metabridge program aims to "accelerate the best & brightest high growth technology Start-ups in Canada."
Sam discusses how we and our collaborators use the LOP™ technology to generate a variety of unique functional 3D human tissues.
See this latest feature in Bloomberg Businessweek...
What if we can 3D print living human tissue to test new drugs and study disease?
We're pleased to announce a research collaboration with University of Manitoba Professor Adrian West.
Watch a feature on Aspect from Global News BC.
Ready to Rocket highlights British Columbia tech companies with high growth potential in life sciences, digital health, cleantech and ICT.
Aspect is pleased to announce that Dr. Peter Zandstra will join the company as an advisor.
Read about our latest news in this feature from the Vancouver Sun, including our latest deal with Johnson & Johnson.
"Printed human body parts could soon be available for transplant"
We announced today that we have entered into a research collaboration with DePuy Synthes Products Inc.
We've been selected to speak at TEDxStanleyPark on March 4, 2017 at Queen Elizabeth Theatre in Vancouver, BC.
We're pleased to announce that we've been selected to join the Canadian Technology Accelerator San Francisco (CTA SF) Life Sciences program.
We're pleased to announce that we have entered into a research collaboration with University of Victoria Professor Stephanie Willerth.
We have announced the appointment of James Hatton and Paul Drohan to our Board of Directors.
CEO Tamer Mohamed's story has been featured by UBC Engineering.
Aspect Biosystems Ltd. is pleased to announce that Mr. Dirk Smith will join the company as an advisor.
We're proud to be sponsoring the Biofabrication 2016 Conference and presenting our poster on 3D Bioprinting.
Today we announced the completion of an oversubscribed financing.
We're pleased to announce that we've been awarded $450,000 CAD in grant funding by the National Research Council.
We've been featured in an article by Vancouver Coastal Health Research Institute.
We've been named winner of the ‘Most Promising Startup’ Award at the BC Tech Association’s 2016 Technology Impact Awards (TIAs).
In this talk, Dr. Sam Wadsworth explains he sees a future full of bioprinted human airways and organs.
Aspect has been featured in one of Gartner's latest reports.
Aspect Biosystems is pleased to announce the appointment of Tamer Mohamed as President and Chief Executive Officer effective May 3, 2016.
3D Bioprinting Tools Provide New Avenues for Medical Research
Aspect Biosystems has been selected among the top tech-based companies in BC to present at #BCTECH Summit in Vancouver, BC.
Aspect Biosystems was recognized by Startup Canada as a BC & the North Regional Winner of the Startup Canada Award for Innovation.
Aspect included on 3Dprint.com list of companies leading the 3D bioprinting space.
Aspect closes oversubscribed seed round funded by the local Vancouver angel community.
Aspect Biosystems wins RBC Royal Bank & Merck Canada's Coast to Coast Company Pitch Competition at BIO 2015
Aspect featured by CTV Vancouver.
Aspect Biosystems is proud to be selected by Ready to Rocket as a 2015 Life Sciences Emerging Rocket.
"Can 3-D Printing of Living Tissue Speed Up Drug Development?"
"Startups tout commercially 3D-printed tissue for drug screening"
Aspect selected as one of the hottest and most promising tech startups in Canada by Techvibes.
"3D Bioprinting: A Deliberate Business"
"The 3D-printed organ is coming, and Canadian firms are leading the way - Industry could be worth billions"
"Within a generation, we likely will not just hear of things like 3D-printed hearts serving as models, but as real, functioning organs."
Aspect featured on CKNW Radio.
"Vancouver’s Aspect Biosystems has created a 3D printer that will bioprint human tissue capable of developing full biological functions."
Aspect featured in the Vancouver Sun.
Aspect earns second place at the 2014 BCIC New Ventures Competition.
Aspect featured by the Ubyssey, newspaper at the University of British Columbia.
Aspect Biosystems featured in BCBusiness.
Aspect receives investment from e@UBC Seed Fund.
Aspect Biosystems featured by UBC News.
Aspect receives federal government support for validation of its first 3D printed tissue product
Aspect Biosystems co-founders Tamer Mohamed and Simon Beyer awarded the CMC MEMSCAP Microsystems Design Award